Jarrod J. Mousa

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +16

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

Jarrod J. Mousa, Nurgun Kose, Pranathi Matta et al. · Nature Microbiology · 2017 · 115 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus

Xiaolin Wen, Jarrod J. Mousa, John T. Bates et al. · Nature Microbiology · 2017 · 94 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5–based COVID-19 vaccine

Dong An, Kun Li, Dawne K. Rowe et al. · Science Advances · 2021 · 92 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

MATE transport of the E. coli-derived genotoxin colibactin

Jarrod J. Mousa, Ye Yang, Sarah Tomkovich et al. · Nature Microbiology · 2016 · 85 citations · Full text

Life Sciences, Microbiology, Molecular Biology +14